Skip to main content
SpringerLink
Log in

Molekulare zielgerichtete Therapieformen

  • Chapter
Molekulare Pharmakologie und Toxikologie

Part of the book series: Springer-Lehrbuch ((SLB))

  • 7328 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 19.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 29.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

5 Molekulare zielgerichtete Therapieformen

  • Airenne KJ, Mähönen, Laitinen OH, Ylä-Herttuala S (2004) Baculovirus-mediated gene transfer: an evolving new concept. In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 181–197

    Google Scholar 

  • Ameri K, Wagner E (2004) Receptor-targeted polyplexes. In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 223–244

    Google Scholar 

  • Barik S (2005) Silcence of the transcripts: RNA interference in medicine. J Mol Med 83: 764–773

    Article  PubMed  CAS  Google Scholar 

  • Barouch DH (2006) Rational design of gene-based vaccines. J Pathol 208: 283–289

    Article  PubMed  CAS  Google Scholar 

  • Barry MA, Singh RAK, Andersson HA (2004) Gene gun technologies: applications for gene therapy and genetic immunization. In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 263–285

    Google Scholar 

  • Bennet CF, Swayze E, Geary R, Levin AA, Mehta R, Teng CL, Tillman L, Hardee G (2004) In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 347–374

    Google Scholar 

  • Buhaescu I, Segall L, Goldsmith D, Covic A. New immunosuppressive therapies in renal transplantation: monoclonal antibodies. J Nephrol. 2005 Sep–Oct; 18(5):529–36.

    PubMed  CAS  Google Scholar 

  • Cannon PM, Anderson WF (2004) Retroviral vectors for gene therapy. In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 1–16

    Google Scholar 

  • Casadevall A, Dadachova E, Pirofski LA (2004) Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2: 695–703

    Article  PubMed  CAS  Google Scholar 

  • Chofflon M (2005) Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach? BioDrugs19: 299–308

    Article  PubMed  CAS  Google Scholar 

  • Cui Z (2005) DNA vaccine. Adv Genet 54: 257–289

    Article  PubMed  CAS  Google Scholar 

  • Davila JC, Cezar GG, Thiede M, Strom S, Miki T, Trosko J (2004) Use and application of stem cells in toxicology. Toxicol Sci 79: 214–223

    Article  PubMed  CAS  Google Scholar 

  • Dillon CP, Sandy P, Nencioni A, Kissler S, Rubinson DA, van Parijs L (2005) RNAi as an experimental and therapeutic tool to study and regulate physiological and disease processes. Annu rev Physiol 67: 147–173

    Article  PubMed  CAS  Google Scholar 

  • Dykxhoorn DM, Liebermann J (2005) The silent Revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med 56: 401–423

    Article  PubMed  CAS  Google Scholar 

  • Faustman DL (2000) Antibodies for transplantation. In: George AJT, Urch CE (eds) Diagnostic and therapeutic antibodies. Humana Press, Totowa/NJ, pp 141–156

    Chapter  Google Scholar 

  • Fleckenstein B, Efferth T (2000) Grundlagen der Gentherapie. In: Verband Deutscher Biol (vdbiol). Aufbruch der Biowissenschaften. Münster, pp 96–100

    Google Scholar 

  • George AJT (2000) The antibody molecule. In: George AJT, Urch CE (eds) Diagnostic and therapeutic antibodies. Humana Press, Totowa/NJ, pp 1–21

    Chapter  Google Scholar 

  • Gleave ME, Monia BP (2005) Antisense therapy for cancer. Nat Rev 5: 468–479

    CAS  Google Scholar 

  • Hackett NR, Crystal RG (2004) Adenovirus vectors for gene therapy. In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 17–41

    Google Scholar 

  • Huang S, Ingber DE (2004) From stem cells to functional tissue architecture. In: Sell S (ed) Stem cell handbook. Humana Press, Totowa/NJ, pp 45–56

    Google Scholar 

  • Jansen B, Zangemeister-Wittke U (2002) Antisense therapy for cancer — the time of truth. Lancet Oncol 3: 672–683

    Article  PubMed  CAS  Google Scholar 

  • Jason TLH, Koropatnick J, Berg RW (2004) Toxicology of antisense therapeutics. Toxicol Appl Pharmacol 201: 66–83

    Article  PubMed  CAS  Google Scholar 

  • Johns M (2000) Phage display technology. In: George AJT, Urch CE (eds) Diagnostic and therapeutic antibodies. Humana Press, Totowa/NJ, pp 53–62

    Chapter  Google Scholar 

  • Jolly D (2004) Lentivoral vectors. In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 131–145

    Google Scholar 

  • Mansoor W, Gilham DE, Thistlethwaite FC, Hawkins RE (2005) Engineering T cells for cancer therapy. Br J Cancer 93: 1085–1091

    Article  PubMed  CAS  Google Scholar 

  • McCart JA, Bartlett DL (2004) Vaccinia viral vectors. In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 165–179

    Google Scholar 

  • Michaeli D (2005) Vaccines and monoclonal antibodies. Semin Oncol 32(6 Suppl9):82–86

    Article  CAS  Google Scholar 

  • Moritz T, Efferth T, Osieka R (2001) Hoffungsträger Gentherapie. Liegt hier die Zukunft der Tumorbehandlung? Münchener Med Wochenschrift 33: 628–631

    Google Scholar 

  • Oral HB, Akdis CA (2000) Antibody-based therapies in infectious diseases. In: George AJT, Urch CE (eds) Diagnostic and therapeutic antibodies. Humana Press, Totowa/NJ, pp 157–178

    Chapter  Google Scholar 

  • Paschen A, Schadendorf D, Weiss S (2004) Bacteria as vectors for gene therapy of cancer. In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 199–209

    Google Scholar 

  • Schwartz RE, Verfaillie CM (2005) Adult stem cell plasticity. In: Odorico J, Zhang SC, Pedersen R (eds) Human embryonic stem cells. BIOS Scientific Publishers, Oxford, pp 45–60

    Google Scholar 

  • Sell S (2004) Stem cells. In: Sell S (ed) Stem cell handbook. Humana Press, Totowa/NJ, pp 1–18

    Google Scholar 

  • Shamblott MJ, Sterneckert JL (2005) Characteristics of human embryonic stem cells, embryonal carcinoma cells and embryonic germ cells. In: Odorico J, Zhang SC, Pedersen R (eds.) Human embryonic stem cells. BIOS Scientific Publishers, Oxford, pp. 29–44

    Google Scholar 

  • Sledz CA, Williams BRG (2005) RNA interference in biology and disease. Blood 106: 787–794

    Article  PubMed  CAS  Google Scholar 

  • Smith R (2000) Antibodies for inflammatory disease. In: George AJT, Urch CE (eds) Diagnostic and therapeutic antibodies. Humana Press, Totowa/NJ, pp 99–114

    Chapter  Google Scholar 

  • Smith T (2002) Ion channels in biological membranes. Online in internet: http://www.chemsoc.org/exemplarchem/2002/Tim_Smith/channels/) (Recherchedatum: 02.02.2006)

    Google Scholar 

  • Sullenger BA, Gilboa E (2002) Emerging clinical applications of RNA. Nature 418: 252–258

    Article  PubMed  CAS  Google Scholar 

  • Sullenger BA, Milich L, Jones III JP (2004) Gene therapy applications of ribozymes. In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 333–345

    Google Scholar 

  • Uprichard SL (2005) The therapeutic potential of RNA interference. FEBS Lett 579: 5996–6007

    Article  PubMed  CAS  Google Scholar 

  • Verma R, Boleti E (2000) Engineering antibody molecules. In: George AJT, Urch CE (eds) Diagnostic and therapeutic antibodies. Humana Press, Totowa/NJ, pp 35–52

    Chapter  Google Scholar 

  • Walsh G. (1998) Antibodies, vaccines and adjuvants. In: Walsh G. Biopharmaceuticals: Biochemistry and Biotechnology. Wiley & Sons, Chichester, pp 337–386

    Google Scholar 

  • Wolfe D, Goins Fink DJ, Burton EA, Krisky DM, Glorioso JC (2004) Engineering Herpes simplex viral vectors for therapeutic gene transfer. In: Templeton NS. Gene and cell therapy. Therapeutic mechanisms and strategies. Dekker, New York Basel, pp 103–129

    Google Scholar 

  • Xu G, MeLeod HL (2001) Strategies for enzyme/prodrug cancer therapy. Clin Cancer Res 7: 3314–3324

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2006). Molekulare zielgerichtete Therapieformen. In: Molekulare Pharmakologie und Toxikologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-48245-1_5

Download citation

Publish with us

Policies and ethics

Search

Navigation